Evidence map›Paper›PMID 40126310›Full record

ArticlePharmacy (Basel, Switzerland)2025

Pharmaceutical Public Health: A Mixed-Methods Study Exploring Pharmacy Professionals' Advanced Roles in Public Health, Including the Barriers and Enablers.

Diane Ashiru-Oredope, Roeann Osman, Adeola H Ayeni, Eleanor J Harvey, Maria Nasim, Emma Wright, Christina Narh, Uju Okereke, Tasmin Harrison, Christopher Garland and 3 more

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Diane Ashiru-OredopeClinical and Public Health Group, UK Health Security Agency, London E14 4PU, UK.
Roeann OsmanClinical and Public Health Group, UK Health Security Agency, London E14 4PU, UK.
Adeola H AyeniPublic Health, Teeside University, Middlesborough TS1 3BX, UK.ORCID 0000-0003-2187-552X
Eleanor J HarveyClinical and Public Health Group, UK Health Security Agency, London E14 4PU, UK.
Maria NasimClinical and Public Health Group, UK Health Security Agency, London E14 4PU, UK.
Emma WrightPublic Health Team, Northumberland County Council, Newcastle NE61 2EF, UK.
Christina NarhPharmacy Department, Barts Health NHS Trust, London E1 2ES, UK.
Uju OkerekeNHS England East Midlands Team, NHS England, Birmingham LE3 8RA, UK.
Tasmin HarrisonPublic Health Action Support Team (PHAST), London SL9 7QE, UK.
Christopher GarlandPharmaceutical Directorate, Department of Health, Belfast BT4 3SQ, UK.
Cecilia PyperPublic Health Action Support Team (PHAST), London SL9 7QE, UK.
Andrew EvansHealth and Social Services Group, Welsh Government, Cardiff CF10 3NQ, UK.ORCID 0000-0001-9486-283X
Marion BenniePublic Health Scotland, Edinburgh EH12 9EB, UK.

Funding

This project was funded in 2020 by the Chief Pharmaceutical Officer, NHS England on behalf of the Chief Pharmaceutical Officers across all four UK nations. NA
6 · The paper itself

Abstract

backgroundIn the UK and globally, pharmacy professionals (pharmacists and pharmacy technicians) contribute to the delivery of local and national public or population health interventions. The existing literature on pharmaceutical public health predominantly focuses on micro-level activities, primarily describing community pharmacies delivering public health interventions to individuals. There is little-known evidence on pharmacy professionals' involvement in delivering public health interventions at meso- (e.g., organisational) and macro (national/policy) levels, nor to what extent pharmacy professionals have specialist/advanced roles within public health practice. This study specifically explored pharmacy professionals' specialist/advanced roles within public health as well as the opportunities and barriers to career development. The analyses of this mixed-methods study makes a series of important recommendations for future action.

methodsThis study included two independent cross-sectional electronic surveys for pharmacy professionals and public health professionals, a call for evidence, and two workshops to develop recommendations.

resultsPharmacy professionals (n = 128) and public health professionals (n = 54) across the UK participated in the surveys. Most of the Pharmacy Professionals respondents were female (70%), pharmacists (85%), working in primary (33%) or secondary (25%) care settings, mainly based in England (75%), and most (63%) lacked formal public health qualifications although they were involved in a diverse range of public health interventions. The public health professionals were mostly females (67%), practicing in England (58%). Both professional groups identified opportunities and barriers to pharmacy professionals' involvement in public health. Almost half of the public health professionals respondents (44%) stated that they had a pharmacy professional working as part of their current public health teams. Eighty-seven percent of public health professional respondents (45/52) agreed that having pharmacists or pharmacy technicians specialising in public health would be beneficial or very beneficial. Most of the documents, reports, and case histories provided through the call for evidence were unpublished. The workshops generated 94 recommendation statements, highlighting collaboration and the need to acknowledge pharmacy professionals' contributions to public health.

conclusionThe recommendations for strategic action at meso- and macro-levels included three main themes: adopting a national strategic approach to pharmaceutical public health, including improving commissioning; formalising pharmaceutical public health workforce development; and promoting further evidence-based pharmaceutical public health research and development.

Indexed as

community pharmacyCORE20PLUSemergency preparedness resilience and responsehealth inequalitiespharmaceutical public healthpharmacoequitypharmacypolicy

Identifiers

PMID40126310
PMCPMC11932277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.